Clinical Scorecard: Utilization of Unilateral Biportal Endoscopy for Minimally Invasive Management of Non-Aggressive Benign Spinal Tumors: A Technical Overview and Initial Clinical Findings

At a Glance

Key Highlights

• 14 patients underwent UBE surgery with no tumor recurrence observed during follow-up
• Mean operative duration was 77.5 minutes with a mean blood loss of 17.5 mL
• Significant improvement in VAS scores at all postoperative timepoints compared to preoperative values
• All patients resumed normal daily activities post-surgery
• UBE represents a minimally invasive option for managing non-aggressive spinal benign tumors

Guideline-Based Recommendations

Diagnosis

• Pathological confirmation of spinal benign tumors is required

Management

• UBE is recommended for non-aggressive benign spinal tumors classified as Enneking Stage S1 and S2

Monitoring & Follow-up

• Follow-up for tumor recurrence and assessment of clinical outcomes is necessary

Risks

• Potential for postoperative complications, although none were reported in this study

Patient & Prescribing Data

14 patients (6 males, 8 females) with non-aggressive spinal benign tumors

UBE surgery demonstrated safety and efficacy in tumor resection

Clinical Best Practices

• Utilize UBE for minimally invasive management of non-aggressive spinal benign tumors
• Monitor VAS scores for assessing pain relief postoperatively
• Ensure thorough preoperative imaging and pathological evaluation

Related Resources & Content